- Benchmark ASINB0H3JM2R1S
- MarketplaceUS
- Category ID3733721
- Analyzed Products
- Keywordhome organizer
- Price Range-
- Minimum Net Profit Margin10.00%
- MOQ100
- Est. Purchasing CostNo price data
- Data Date2026-07-23
- Your Budget (for new listing) (CNY)¥500,000.00
Report summary from Keble AI Agent: Listing
这个市场不值得进入，而且对大品牌和小商家都不是机会：当前新品牌只有 Marsail，2个新上架产品全部亏损，新的成功率是0.00%，样本虽然不大，但已经足够说明市场没有给新进入者留下可复制的盈利窗口。更关键的是，产品同质化严重、利润被压得很薄，已经不是“能不能做”的问题，而是“做了也很难赚钱”。
证据很直接：Marsail 的 B0H3JM2R1S 标价 549.99 美元，按现有成本结构算下来毛利率看起来有 39.61%，但实际仍然不盈利，说明这类产品的真实问题不是定价，而是竞争和附加成本把利润吃掉了；另一款 B0G3RRLDRG 也同样亏损。产品失败原因一致，都是缺乏独特性、目标人群过宽、市场太小或竞争太激烈。从时间上看，2025/11 和 2026/6 两次新发布都没有跑出正向结果，市场趋势不是上升窗口，而是在持续走向更强的价格压力。对小商家来说，这类市场如果硬进，往往需要更激进的营销手段才能抢量；对大品牌来说，就算有预算，也仍然要面对同质化和利润被压缩的问题。用户当前预算 500000 CNY 表面上能覆盖单个 ASIN 的前期启动，但这还不包含研发、品牌和认证，预算不构成安全入场条件。
- 大品牌：没有明确可复制的成功样本可追，Marsail 这类新入局者已经全线失败，说明重投入也未必能打穿。
- 小商家：没有真实的低门槛成功案例；如果没有明显产品差异、设计差异或渠道优势，不建议进入。
- 结论：这是一个高风险、低回报、明显同质化的市场，当前应直接避开。
Recommended Products Features Direction
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
New Brands
VS
Old Brands
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
New Brands
#Budget Requirement
Listing结论很明确：这个市场不值得进入。 当前样本里新品牌新上架产品盈利率是0%，整体可判定为高风险、低回报市场；而且产品高度同质化，没有明显差异化卖点，已经呈现出价格竞争和比拼投入的特征。
Early sourcing + logistics + marketing budget (USD)N/AExplains the budgetWith all these investments, who has profitable new releases
How many new listings are released by old brands?0.00%New listing success rate (new brands):0.00%Alternatives- 人体工学座垫/尾骨减压坐垫：比整把办公椅便宜得多，直接改善久坐压迫和腰部不适，适合已有椅子但想提升舒适度的用户。
- 可调式脚踏凳：成本低、上手简单，能改善坐姿角度和腿部循环，是“先缓解久坐疲劳”而不是直接换椅子的替代方案。
- 腰靠垫/护腰靠枕：无需更换家具，安装即用，适合办公室或家里已有椅子的用户，能以更低价格获得类似的腰部支撑。
- 可折叠便携坐垫/楔形坐垫：更轻、更便宜，也更容易搬动，适合租房、临时工位或多场景切换的人群。
- 站立办公入门替代方案（桌面增高架/简易升降台）：如果用户购买椅子的核心诉求是减轻久坐，可先用更低门槛的站立切换方案分散坐姿压力。
- 二手办公椅/翻新人体工学椅：价格通常远低于新品高配椅，适合预算敏感且愿意接受轻微外观磨损的用户。
- 可替换轮椅/椅脚配件升级：针对已有椅子，花小钱升级静音轮、脚垫或气压杆，比整椅购买更省钱，也更容易落地。
Alternative solutions may pose a risk to your investment in certain markets.
#Brands Investment Analysis
Listing这个市场不建议进入，结论非常明确：当前样本里新进入品牌几乎没有成功案例，且 100% 的新品牌新上架产品都没过盈利线，市场信号是直接偏差、不是机会。 现在看到的 Marsail 不是可复制的成功样本，而是一个高投入但没跑通的失败案例；在你给出的 50 万人民币预算下，这类重型产品的前期投入看起来能覆盖一部分，但不足以证明长期能打赢，尤其还要补品牌、内容和后续拉新成本。
New products with Highest revenueLeast investment in new productsMost investment in new productsMarsail
Recent Monthly Revenue (USD):-(-)B0H3JM2R1S (4.5/5 (222 Reviews))Brand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQRecent Monthly Revenue (USD):-(-)B0G3RRLDRGBrand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQ#Differentiations
Unique productsCommon productsDifferentiation:- Product features and designs are too common without differentiation
B0H3JM2R1S (4.5/5 (222 Reviews))Brand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQSales & BSR
Differentiation:- Product features and designs are too common without differentiation
B0G3RRLDRGBrand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQSales & BSR
#Net Profit Margins: All vs New
Listing结论很明确：这个市场不值得进入，属于高风险且偏饱和的价格战市场。 现有样本里，新品牌进入后成功率为0%，两款新上架产品全部亏损；市场里已经出现“低利润、同质化、靠堆配置却难赚钱”的典型信号，做大品牌或小商家都不应把它当成可轻松切入的机会。
证据很直接：Marsail 作为新入场品牌，2个产品全部不盈利，成功率0%；两款ASIN分别是 B0G3RRLDRG 和 B0H3JM2R1S，其中 B0H3JM2R1S 标价 549.99 美元但仍不盈利，说明价格并不能换来利润，核心问题是产品差异不够。失败原因也一致，都是“缺乏独特性”“市场太小或竞争太激烈”，B0H3JM2R1S 还被标注为“看起来不错但利润太低”。再看时间趋势，2025到2026连续出现的新上架都没有跑出正向结果，显示市场并没有给新品牌留出明显窗口；按你给的标准，这种“新品牌成功率远低于10%”的市场就是高风险，且当前样本已经足够说明问题。
Profitability difficultyUnknown - Insufficient New ReleasesAll products distribution on different profit levels
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%otherNew products distribution on different profit levels
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%other#Top Products by Net Profit Margin
Top 20 Non-Profitable Products
Products with negative profitability ranked by lowest profit value. Only includes products classified as non-profitable regardless of release date.
B0H3JM2R1SMarsail2026-06-01No$549.99-pcs$-39.61%$-B0G3RRLDRGMarsail2025-11-24No$--pcs$--%$-Top 20 Non-Profitable New Products
New products with negative profitability ranked by lowest profit value. Only includes newly released products classified as non-profitable.
B0H3JM2R1SMarsail2026-06-01No$549.99-pcs$-39.61%$-B0G3RRLDRGMarsail2025-11-24No$--pcs$--%$-#New Product Success Rates
Listing这个市场不值得进入，已经是高风险价格战环境。 新品整体盈利率为0%，新品牌新品盈利率也为0%，而且已出现明确的零利润新入局品牌 Marsail，说明现在不是“谁先做谁赢”，而是“做了也很难赚钱”。
从数据看，市场里可识别的盈利产品占比是0.00%，新发布产品盈利率也是0.00%；Marsail 作为新入局品牌，2个产品全部亏损，代表性 ASIN 是 B0H3JM2R1S（售价 549.99 美元，未见盈利）和 B0G3RRLDRG（同样亏损）。产品失败原因非常一致：同质化严重、缺少独家卖点、目标人群过宽，说明这个赛道不是靠简单上架就能跑出来的。更关键的是，样本里没有看到任何真实的“小品牌轻松成功”案例；反而是新品牌也全军覆没，意味着小商家想合法进入，胜率很低。若要和强势玩家对打，预算往往不止覆盖前几个月的进货、物流和投放，还要额外承担研发、品牌和认证成本，500000 CNY 也不等于足够安全。
结论很直接：大品牌不应进入，小商家也不应进入。 这不是一个“可复制成功”的市场，而是一个当前已呈现失败率极高、同质化严重、需要重投入却仍可能亏损的市场。
New products success rate.
What is the ratio of profitable products
Profitable (Unidentifiable released date)Profitable (Old product)Profitable (New product)Profitable (New product on old listing)New products but non profitableNo data availableNonprofitable new products divide by brands
What is the ratio of different brands owning all nonprofitable new products
Marsail#Success Rate by Entry Time
Listing这个市场不值得进入，结论很明确：新品牌几乎没有成功样本，已经进入明显的价格战/高风险区。 你现在的预算是50万CNY，表面上够做单个ASIN的前期启动，但市场里最近两条新品牌入场记录全部失败，成功率是0%，而且近一年和近几个月都没有任何可验证的盈利新进入者，说明不是“容易做”，而是“做进去也很难活下来”。
How many products released each year
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
How many products released each month
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
#Net Profit Margins by Entry Time
Different profit ratios of products released in year
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2022 0 0 0 0 0 0 0 0 2023 0 0 0 0 0 0 0 0 2024 0 0 0 0 0 0 0 0 2025 0 0 0 0 0 0 0 1 2026 0 0 0 0 0 0 0 1 ≥ 10% Profitable< 10% UnprofitableUnidentifiableDifferent profit ratios of products released in month
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2025/7 0 0 0 0 0 0 0 0 2025/8 0 0 0 0 0 0 0 0 2025/9 0 0 0 0 0 0 0 0 2025/10 0 0 0 0 0 0 0 0 2025/11 0 0 0 0 0 0 0 1 2025/12 0 0 0 0 0 0 0 0 2026/1 0 0 0 0 0 0 0 0 2026/2 0 0 0 0 0 0 0 0 2026/3 0 0 0 0 0 0 0 0 2026/4 0 0 0 0 0 0 0 0 2026/5 0 0 0 0 0 0 0 0 2026/6 0 0 0 0 0 0 0 1 ≥ 10% Profitable< 10% UnprofitableUnidentifiable#Case Study
Success Cases